Deep Penetrating Nevus and Borderline-Deep Penetrating Nevus: A Literature Review.

Front Oncol

Division of Health Care Sciences, Center for Clinical Research and Management Education, Dresden International University, Dresden, Germany.

Published: May 2020

Deep penetrating nevi (DPN) are rare melanocytic nevi, which can exhibit atypical histological features hampering the differentiation from malignant melanoma. DPN are considered benign melanocytic lesions, but rare spread to lymph nodes and unfavorable clinical outcomes associated with borderline/atypical DPN (B-DPN) has been reported. Since no guidelines are available for DPN and B-DPN, we aimed to review the literature on DPN and B-DPN to assess the management and prognosis. We screened 3,513 references from EMBASE, Scopus and Medline databases, and included 15 studies with a total of 355 DPN patients and 48 B-DPN patients. Therapeutic interventions ranged from simple excision to wide excisions and sentinel lymph node biopsy (SLNB), with block lymph node dissection in some positive SLNB cases. Follow-up periods ranged from 3 months to 23 years during which a total of five recurrences, two in DPN and three in B-DPN group, and three metastases, in B-DPN group, were reported. While some of the included studies comprised clinical and histopathological correlation, few included genetic assessment. The present review highlights the need for prospective cohort studies applying composite measures to identify effective regimens of diagnostic workup and treatment in DPN and B-DPN.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251176PMC
http://dx.doi.org/10.3389/fonc.2020.00837DOI Listing

Publication Analysis

Top Keywords

dpn b-dpn
16
deep penetrating
8
penetrating nevus
8
dpn
8
included studies
8
lymph node
8
b-dpn group
8
b-dpn
7
nevus borderline-deep
4
borderline-deep penetrating
4

Similar Publications

Several new bifunctional salts, Li[B(DPN)], Li[B(DPN)(ox)] and Li[P(DPN)], have been prepared from the phosphorus(v)-containing chelating ligand 2,3-dihydroxynaphthalene-1,4-(tetraethyl)bis(phosphonate) (H-DPN). The new lithium salts were characterized by a variety of spectroscopic techniques. Both H-DPN and Li[B(DPN)] have been structurally characterized by X-ray crystallographic methods.

View Article and Find Full Text PDF

Deep Penetrating Nevus and Borderline-Deep Penetrating Nevus: A Literature Review.

Front Oncol

May 2020

Division of Health Care Sciences, Center for Clinical Research and Management Education, Dresden International University, Dresden, Germany.

Deep penetrating nevi (DPN) are rare melanocytic nevi, which can exhibit atypical histological features hampering the differentiation from malignant melanoma. DPN are considered benign melanocytic lesions, but rare spread to lymph nodes and unfavorable clinical outcomes associated with borderline/atypical DPN (B-DPN) has been reported. Since no guidelines are available for DPN and B-DPN, we aimed to review the literature on DPN and B-DPN to assess the management and prognosis.

View Article and Find Full Text PDF

Objective To determine the effect of ropivacaine on peripheral neuropathy in diabetic rats and its possible mechanism. Methods Forty-eight Sprague-Dawley rats were randomly divided into six groups: nondiabetic control group, nondiabetic group A (0.25% ropivacaine), nondiabetic group B (0.

View Article and Find Full Text PDF

The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.

Ann Diagn Pathol

June 2017

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. Electronic address:

Background: FISH has recently emerged as a technique to better assess the malignant potential of histologically ambiguous melanocytic lesions. However, the usefulness of FISH has not been conclusively established. The purpose of this study was to further explore the diagnostic value of FISH in distinguishing the borderline melanocytic tumor (BMT) from melanoma.

View Article and Find Full Text PDF

Background: The borderline melanocytic tumor (BMT) is a morphologically and biologically indeterminate melanocytic proliferation manifesting worrisome architectural features and cytologic atypia exceeding that encountered in melanocytic nevi yet insufficient to warrant designation as melanoma. The criteria that define the BMT are not well defined nor is the concept widely recognized.

Objective: The purpose of this study is to provide a practical framework for the approach to the dermal BMT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!